Show simple item record

dc.contributor.authorSteiner, Robert A.en_US
dc.contributor.authorBremner, William J.en_US
dc.contributor.authorBagatell, Carrie J.en_US
dc.date.accessioned2008-10-17T20:42:35Z
dc.date.available2008-10-17T20:42:35Z
dc.date.issued1991-09en_US
dc.identifier.citationJ Clin Endocrinol Metab. 1991 Sep;73(3):465-9en_US
dc.identifier.urihttp://hdl.handle.net/1773/4428
dc.description.abstractNo effective hormonal contraceptive has yet been devised for men. Through their suppressive effect on gonadotropin secretion, GnRH antagonists inhibit both testosterone (T) production and spermatogenesis in animals. Long term administration of an antagonist alone would result in androgen deficiency; this would cause unacceptable physiological and behavioral sequellae in men. Therefore, androgen replacement must be included in any GnRH antagonist regimen used in human male contraception. We tested the hypothesis that the combination of a GnRH antagonist plus T would suppress spermatogenesis in the male primate to azoospermic levels while maintaining normal serum T levels. We examined the effects of the GnRH antagonist Deterelix [N-Ac-DNal(2)1-DpCl-Phe2-DTrp3-DhArg(Et2)6 -DAla10-GnRH], alone and with simultaneous T replacement, on sperm production and serum T levels in adult male monkeys (n = 22). After 12 weeks of daily sc antagonist injection, all animals that received antagonist alone (n = 5) and those that 750 micrograms/kg.day antagonist plus T (n = 5) were azoospermic. After 16 weeks, four of five animals that received 250 micrograms/kg.day antagonist plus T became azoospermic. Control animals (n = 7) received daily injections of vehicle; sperm counts increased somewhat during the study period in that group. Castrate range T levels were achieved in animals receiving antagonist alone. T levels in the groups that received T supplementation and in the control group were in the normal male range throughout the treatment period. Sperm counts returned to the pretreatment range in all animals during the recovery period. We conclude that the combination of a GnRH antagonist plus T can induce azoospermia reversibly in this nonhuman primates species, and that a similar combination may be an effective contraceptive regimen in men. The GnRH antagonist alone may be an effective treatment for androgen-dependent neoplasia.en_US
dc.language.isoen_USen_US
dc.publisherEndocrine Societyen_US
dc.subjectandrologyen_US
dc.subject5-alpha reductase inhibitorsen_US
dc.subjectklinefelter's syndromeen_US
dc.subjectspermatogenesisen_US
dc.subjectreifenstein's syndromeen_US
dc.subjectcolchicineen_US
dc.subjectmale contraceptionen_US
dc.subject.meshResearch Support, U.S. Gov't, Non-P.H.S.en_US
dc.subject.meshMaleen_US
dc.subject.meshSpermatogenesis, drug effectsen_US
dc.subject.meshTestis, cytology, drug effectsen_US
dc.subject.meshResearch Support, U.S. Gov't, P.H.S.en_US
dc.subject.meshContraceptive Agents, Male, pharmacologyen_US
dc.subject.meshTestosterone, blood, pharmacologyen_US
dc.subject.meshSpermatozoa, drug effectsen_US
dc.subject.meshGonadorelin, analogs & derivatives, antagonists & inhibitors, pharmacologyen_US
dc.subject.meshMacaca fascicularisen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.subject.meshAnimalsen_US
dc.subject.meshBody Weight, drug effectsen_US
dc.titleGonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptiveen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record